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Abstract
Background: As life expectancy increases and the number of older people, particularly those aged 85 years and
over, expands there is an increase in demand for long-term care. A large proportion of people in a care home
setting spend most of their time sedentary, and this is one of the leading preventable causes of death. Encouraging
residents to engage in more physical activity could deliver benefits in terms of physical and psychological health,
and quality of life. This study is the final stage of a programme of research to develop and preliminarily test an
evidence-based intervention designed to enhance opportunities for movement amongst care home residents,
thereby increasing levels of physical activity.
Methods/design: This is a cluster randomised feasibility trial, aiming to recruit at least 8–12 residents at each of 12
residential care homes across Yorkshire, UK. Care homes will be randomly allocated on a 1:1 basis to receive either the
intervention alongside usual care, or to continue to provide usual care alone. Assessment will be undertaken with
participating residents at baseline (prior to care home randomisation) and at 3, 6, and 9 months post-randomisation.
Data relating to changes in physical activity, physical function, level of cognitive impairment, mood, perceived health
and wellbeing, and quality of life will be collected. Data at the level of the home will also be collected and will include
staff experience of care, and changes in the numbers and types of adverse events residents experience (for example,
hospital admissions, falls). Details of National Health Service (NHS) usage will be collected to inform the economic
analysis. An embedded process evaluation will obtain information to test out the theory of change underpinning the
intervention and its acceptability to staff and residents.
Discussion: This feasibility trial with embedded process evaluation and collection of health economic data will allow
us to undertake detailed feasibility work to inform a future large-scale trial. It will provide valuable information to
inform research procedures in this important but challenging area.
Trial registration: ISRCTN registry, ISRCTN16076575. Registered on 25 June 2015.
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Background
Life expectancy has increased dramatically over the last
century. While policy and service developments have
emphasised alternatives to long-term care, evidence sug-
gests that around one in four older people will spend
time in a care home in their last year of life [1] and that
the need for such care will persist [2]. In 2011, more
than a quarter of a million (291,000) people aged 65 years
and over were living in care homes in England and
Wales, 3.2% of this population [3].
Research over decades reports that care home resi-
dents spend the majority of their time inactive [4]. Lack
of engagement in physical activity (PA), defined as “any
bodily movement produced by skeletal muscles that re-
sults in energy expenditure” [5], has detrimental effects
on physical and psychological health and quality of life,
and contributes to social isolation [6]. Additionally, an
observational study suggests that 97% of residents’ days
are spent sedentary (e.g. sitting, watching television),
with low levels of interaction with staff and each other
[4]. Sedentary behaviour, defined as “any waking behav-
iour characterised by an energy expenditure ≤1.5 meta-
bolic equivalents (METs) while in a sitting or reclining
posture” [7], has been seen to negatively impact mor-
bidity and mortality independently of PA [8]. Conse-
quently, the National Institute for Health and Care
Excellence (NICE) [9] issued a quality standard call for
“older people in care homes to be offered opportunities
during their day to participate in meaningful activity that
promotes their health and mental wellbeing”. Meaning-
ful activity can range from activities such as caring for
plants and helping around the home, to leisure pursuits
such as playing cards.
Existing research has primarily involved the delivery of
time-limited interventions by staff external to the care
homes [10]. It seems necessary that, if such interven-
tions are to be successfully and sustainably delivered,
they need to be embedded in routine practice and that
care home staff should be involved in developing and
delivering the necessary change [11]. Further, there is in-
creasing emphasis on programmes which reduce the
overall time spent sedentary [12] and that do not simply
involve short bursts of formally organised PA such as ex-
ercise classes. Together, these reinforce the need for ac-
tion to increase levels of PA in care homes, reduce time
spent sedentary, and incorporate greater engagement of
care home staff in developing and delivering whole prac-
tice change which is embedded in daily life routines.
Through a series of studies we have collaborated with
care home staff and residents to develop a multi-
component intervention aimed at changing how the rou-
tine work of care staff is carried out to encourage and
support residents to engage in more PA (above and be-
yond organised exercise sessions) and reduce the time
they spend sedentary. Increasing resident PA and redu-
cing the time they spend sedentary will, we hypothesise,
improve residents’ physical and psychological outcomes.
The first study for the Research Exploring Physical
Activity in Care Homes (REACH) programme involved
ethnographic fieldwork in four care homes to under-
stand the contextual and organisational factors that
shape care practice, residents’ existing patterns of PA,
and the potential for change. It emerged in this first
study, and was reinforced in later studies, that ‘physical
activity’ was a difficult concept for care home staff to
understand and engage with, particularly in view of the
frailty of many residents. Staff linked the notion of PA
with specific time-limited activities which might be
undertaken by an activity co-ordinator. Our intent was
to engage all staff in encouraging residents to undertake
small changes in their daily life. The notion of increasing
movement and ‘moving more’ had greater resonance and
intuitive understanding for staff and residents. Thus, this is
the language we adopted in the care home setting. We
anticipate that ‘moving more’ will increase levels of PA.
The second study explored the acceptability, validity,
and reliability of different measures of PA and sedentary
behaviour, which included the development and testing
of protocols for the use of accelerometers by residents.
In the third study, the researchers worked alongside a
reference group of care home managers, staff, residents,
and their relatives/friends to identify barriers and oppor-
tunities for change through the process of intervention
mapping [13].
In the fourth study, through an action research ap-
proach with care home staff and residents in a further
four homes, we developed and tested elements of an
intervention and change process to reduce residents’
sedentary time and encourage them to ‘move more’. An
iterative approach, drawing on the previous work and
the implementation literature, was utilised during this
process. A novel feature of the work was the involve-
ment of an artist to capture and illustrate pictorially the
voice of residents, which resonated with staff in a way
that words did not.
Here, we report the protocol for the fifth study,
designed to explore the feasibility of training staff to
incorporate the intervention into their care home, and
the feasibility of trial processes (recruitment, follow-up,
data collection) to inform the feasibility and design of a
future definitive randomised controlled trial (RCT).
Methods/design
Design
The REACH feasibility trial is a pragmatic, multicentre,
cluster-randomised controlled trial to explore the practi-
cality and acceptability of implementing a large-scale de-
finitive cluster RCT comparing the REACH intervention
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plus usual care versus usual care practice alone among
permanent residents living in residential care homes in the
UK. The REACH intervention is a whole-home interven-
tion designed to assist care home staff to make step-by-step
changes in their approach to working with residents, and
therefore the care home is the unit of randomisation.
Figure 1 illustrates the timing of all trial processes
(Additional file 1).
Objectives
The study objectives relate to the feasibility trial and the
linked process evaluation. The former will involve
gathering data around recruitment and follow-up, inter-
vention delivery, assessment of outcome measures, and
statistical aspects to inform the feasibility and design of
a definitive RCT. The process evaluation, drawing on
Medical Research Council guidance on process evalua-
tions [14], will collect data relating to the ‘how’ of the
intervention and implementation process (the ‘theory of
change’ or assumptions underpinning the programme);
the process and quality of implementation as it evolves
in real time [15]; and how implementation impacts on,
and is shaped by, the organisational and interactional
environment of the care home [16].
In summary, the main objectives are to:
1. Explore the optimum strategies to facilitate
recruitment, and estimate recruitment and follow-up
rates at both care home and resident levels;
2. Assess the compliance and feasibility of wearing an
accelerometer to obtain data to measure the level of
a resident’s PA (anticipated primary outcome for the
definitive RCT) and time spent sedentary;
3. Evaluate the most appropriate outcome measures by
assessing the feasibility of obtaining questionnaire
data among residents related to physical function,
ability and mobility, and psychological well-being;
4. Determine the optimum strategy for collecting data
relating to health care resource use and adverse events.
The reliability of routinely collected data at both the
care home and resident level will also be considered;
5. Assess intervention fidelity in terms of exposure,
reach, and quality of implementation, as well as the
acceptability to staff and their understanding of the
intervention;
6. Explore factors contributing to and hindering
organisational and practice change, and the
contextual factors that affect variation in the
outcomes achieved;
7. Investigate the characteristics of usual care within
residential care homes;
Fig. 1 SPIRIT figure
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8. Provide a preliminary estimate of the effectiveness
of the intervention as measured by the volume and
level of PA undertaken and the time spent sedentary
from the accelerometer data;
9. Calculate reliable estimates to inform the sample
size calculations for a definitive trial by assessing the
variability in study outcomes in both arms,
estimating the intra-cluster correlation coefficient
(ICC), and estimating likely cluster size and
corresponding between-cluster variability;
10. Investigate the within-trial and long-term incremental
cost effectiveness of the intervention compared with
usual care.
Recruitment setting and participants
The study will be conducted in 12 residential care
homes in the counties of West and North Yorkshire in
the UK. A care home will be considered eligible if:
1) Initial scoping indicates that there are sufficient
numbers of permanent eligible residents to enable
8–12 permanent residents to be recruited from that
home (homes will later be excluded if researchers
find that they are unable to obtain consent and
baseline data for at least 5 residents); and
2) There is a manager or nominated person who agrees
to sign up to the trial protocol as research lead for
the duration of the project and to release staff time
for data collection, including supporting the use of
the accelerometers and, where appropriate,
intervention implementation. Signed agreement is
required from the care home manager and care
home owner or representative.
A care home will be excluded if:
1) In the view of the research team it is not suitable for
inclusion due to being subject to Care Quality
Commission (CQC) enforcement notices, admission
bans, or relevant moderate or major CQC
compliance breaches;
2) It is receiving other special support for specific quality
concerns, such as being currently subject to, or have
pending, any serious safeguarding investigations, or
receiving voluntary or compulsory admissions bans,
or is in receipt of local commissioning special support
due to quality concerns;
3) It has taken part in any of the earlier studies within
the REACH programme;
4) It is taking part, has recently taken part, or is
planning to take part, in another trial or initiative
that conflicts with the REACH intervention or
with the data collection during the course of trial
involvement.
All residents in a care home will be exposed to the inter-
vention should the home be allocated to the REACH
intervention. Those considered eligible for individual
outcome assessment will be permanent residents aged
65 years or over, not terminally ill nor permanently
bedbound, and appropriately consented. A permanent
resident is defined as residing in the care home and not in
receipt of respite, day-care, or short-term rehabilitation.
Care home recruitment and consent
All residential care homes in a pre-specified catchment
area of West Yorkshire will be identified via the CQC
website and assessed for eligibility, as far as is possible,
via publicly available information. Those deemed poten-
tially eligible at this stage will receive an information
sheet via the post with a reply slip to register interest in
participation (a copy of this can be found in Additional
file 2). Researchers will contact care homes to answer
any queries and determine their interest if a reply slip is
not returned within 2 weeks. For interested care homes,
a researcher from the Academic Unit of Elderly Care
and Rehabilitation (AUECR) will complete an initial eli-
gibility assessment via telephone ahead of visiting the
care home to determine full eligibility, obtain agreement
to participate, and complete the recruitment process.
Documented reasons for ineligibility and declining par-
ticipation will be closely monitored by the trial team at
each stage. The target is for a minimum of two care
homes to be recruited per month.
To ensure the sample of 12 care homes is reached, in
close liaison with Clinical Research Network staff, the
Enabling Research in Care Homes (ENRICH; http://
enrich.nihr.ac.uk/) network will be contacted to assist
with identifying homes in an additional catchment area.
All care homes registered on the ENRICH network in
the York and Harrogate areas of North Yorkshire will be
sent the information sheet via email with contact details
to register interest in participation. Colleagues from the
local Clinical Research Network will follow-up contact
with care homes if no response has been received within
2 weeks. For interested care homes, eligibility will be
assessed by the study researcher via telephone and visit
as outlined above.
Resident recruitment and consent
Following care home agreement to participate, all residents
will be screened for eligibility. Demographic data will be re-
corded anonymously by the researcher through discussions
with the care home manager and staff members who know
the residents well. Residents will not be identified to the
researcher by name, and any information provided will be
differentiated only by a screening number.
An initial assessment of the capacity of each eligible
resident to consent will be undertaken by the manager
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or nominated deputy. All residents will be assumed to
have capacity unless assessed to lack capacity in accord-
ance with the Mental Capacity Act (MCA) 2005 guid-
ance [17]. Those with capacity will be provided with
information about the study by the researcher and of-
fered at least 24 h to consider participation if they wish.
Formal written consent to take part will be sought by
the researcher, and ongoing informal capacity assess-
ments conducted by the researcher at each follow-up
visit. If a resident’s capacity is uncertain after initial
assessment, the researcher will be asked to assist in
determining capacity alongside a member of staff if the
resident is willing (Fig. 2).
Recruitment of those without capacity
It is anticipated that many of the residents will lack the
capacity to consent. The MCA requires that those lack-
ing capacity are only included in research that is likely
to be of direct benefit to those taking part or to benefit
the particular population under study. In this trial, the
intervention is delivered at the care home level, hence
all residents may benefit directly from enhanced routine
PA and indirectly through increasing social engagement.
Excluding those without capacity would compromise the
generalisability of findings by recruitment of an unrepre-
sentative study sample and excluding this vulnerable
population from the benefits of research evidence in im-
proving practice.
Research Ethics Committee (REC) approval includes
agreement to involve residents lacking capacity and the
process to include them, namely to seek personal
consultee or nominated consultee agreement for such
residents to participate. For those residents who lose
capacity during study participation following the
provision of informed consent, an identified consultee
will provide advice on a resident’s continued involve-
ment in the trial. Reasons for non-consent, ineligibility,
or declining participation either by the resident them-
selves or their consultee will be closely monitored by the
trial management team as part of a regular review of the
recruitment process.
All resident and consultee information and consent
documentation can be found in Additional file 2.
Care home randomisation
Care homes will be randomised on a 1:1 basis to the
REACH intervention plus usual care or to usual care
alone. Due to the small numbers of care homes (trial
clusters), stratified randomisation will be implemented
to ensure balance between the arms with respect to size
of the care home (small/medium ≤40 beds, large >40
beds) and whether or not an activity co-ordinator is in
post (characteristics expected to be correlated with inter-
vention implementation and outcome evaluation).
The allocation will be performed centrally by the stat-
istician at the Clinical Trials Research Unit (CTRU) at
the University of Leeds using a computer-generated
minimisation program with a random element, following
recruitment of residents and completion of their baseline
assessments. CTRU will provide the random allocation
to researchers involved in intervention implementation
and adherence monitoring, so that all care home man-
agers can be informed of their care home’s allocation,
and arrangements can be put in place for those homes
randomised to intervention delivery. Researchers in-
volved in the collection of outcome measures will not be
informed of allocation, and efforts will be made to en-
sure that they remain blind. This will include maintain-
ing separate office locations for ‘blinded’ and ‘unblinded’
researchers and requesting that care homes do not
disclose their allocation to these researchers.
Due to the concern that smaller homes may not have
enough residents providing baseline data to ensure suffi-
cient outcome data for evaluation (despite initial assess-
ment that there should be 8–12 eligible residents at the
care home), homes will only be randomised if there are at
least five participating residents providing baseline data.
Intervention and implementation process
The REACH intervention is designed to be implemented
and embedded in routine care delivery within the care
home. It has been cumulatively built up from our earlier
work and aims to achieve change in how all members of
staff work with residents to encourage and support them
to engage in more PA and spend less time sedentary.
This will utilise the terminology ‘moving more’. The
intervention will focus on change in four domains of
daily routines that embrace: independent/supervised
movement of residents to get about; incorporating
movement in social and leisure activities; providing
opportunities for residents to engage in ‘meaningful’
activities; and encouraging residents to do as much of
their own self-care and instrumental activities of daily
living as is possible for them.
Implementation will comprise a cyclical service
improvement approach. It will be led by a team in-
volving key stakeholders in the change: staff, residents
(if possible), and their relatives/friends facilitated by a
senior member of care home staff. This synthesises a top-
down and bottom-up approach to leading change [18];
this means that the active involvement of senior staff with
the authority and legitimacy to drive the change process
forward is aimed at securing organisational commitment
to introducing and embedding the programme (top-
down), and the engagement of those directly involved in
action to deliver it ensures that their views and ex-
periences will inform the pace and direction of change
(bottom-up) [19, 20].
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The intervention and implementation process does
not prescribe particular kinds of changes that staff
should make to increase residents’ movement, but re-
mains flexible to be adapted to each care home’s needs.
Several strategies are in place to support implementa-
tion: identification of an intervention lead and core team
in each home; provision of a manual, including an ‘Ideas
Bank’ of resources to assist staff in getting started and
keeping going; and training and support comprising a
series of three interactive workshops provided indivi-
dually to each home.
We have been guided by the template for intervention
description and replication (TIDieR checklist [21]) and
the treatment fidelity framework provided by the
National Institutes of Health’s Behavioral Change
Consortium [22] to capture the intervention (its rationale,
materials, procedures, etc.) and to guide approaches to
implementation and fidelity monitoring.
Resident Screening
Initial eligibility assessment by Care Home 
staff and researcher
Eligible Not Eligible
Assessment of Mental Capacity
Assessed by Care Home staff initially
Main carer (Personal Consultee) provided with trial 
information
Identified and approached by Care Home staff and through 
consultation with the Resident if appropriate.
Known to have capacity Known to not have capacity
Does not have capacity
Researcher assessment of 
capacity
Alongside staff member (if resident 
willing)
Capacity established
Information provision
Care Home Staff seek resident’s permission for 
Researcher to speak to him / her alongside member of 
staff to discuss trial & provide resident information sheet.
Consents Does not 
consent
Assents*
Does not assent Does not 
respond
Staff Member (Nominated Consultee) 
provided with trial information
Assents* Does not 
assent
Registered for trial participation
Baseline assessment completed for all consenting / assenting residents
* This includes resident consultation
Capacity uncertain
Fig. 2 Process for assessing capacity and obtaining consent
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Usual care
Usual care is defined as ‘normal’ care delivered within
the care home and will continue in both arms. No re-
strictions will be imposed on current practices or on
care homes undertaking additional training and develop-
ment as part of usual care. Details of general day-to-day
activities will be recorded via researcher observations
within public areas of a care home and completion of a
pro-forma developed for the purposes of this study.
Trial data collection
The intention is that the intervention becomes embed-
ded within the care home (if so randomised); thus it is
important to assess the impact of the intervention on
the care home as a whole. Consequently, data will be
collected at the level of the care home (including staff )
as well as from individual consenting residents at base-
line (prior to randomisation) and at 3, 6, and 9 months
post-randomisation. Data will be collected by trial re-
searchers who will visit each participating care home at
each follow-up time point. Personal information will be
held centrally, in accordance with consent, by the re-
search team to facilitate follow-up contact, but will be
stored and processed separately to all other data col-
lected for the purposes of the trial. In order to assess
level of blinding, all outcome assessors will be asked to
report immediately if they are unblinded.
A summary of all assessments to be used is provided
in Table 1.
Care home-level data
The care home manager/nominated staff member will
be asked to complete a care home booklet to provide in-
formation on the staff and resident profile of the home,
and anonymous home-level data relating to hospital ad-
missions, general practitioner (GP) call-outs, mortality
rates, and falls in the last 3 months. At baseline, as part
of the screening process, anonymous Physical Activity
and Mobility in Residential Care Scale (PAM-RC) (Whit-
ney et al. manuscript submitted) and Barthel Index [23]
data will also be collected for all residents to establish
the profile of PA, participation in activities of daily liv-
ing/self-care at the level of the care home, and ambula-
tory capacity.
Staff data
At each data collection time point all staff who have face-
to-face contact with residents, with the exception of those
acting as a nominated consultee, will be asked to provide
basic demographic data about themselves and complete a
questionnaire regarding their experience of person-
centred care provided in the care home (Person-centred
Care Assessment Tool (P-CAT)) [24].
Resident-level data
Participating residents will be asked to complete ques-
tionnaires (via researcher interview) assessing their level
of cognitive impairment (six-item Cognitive Impairment
Test (6-CIT)) [25], mood (Geriatric Depression Scale
(GDS)) [26], perceived health (EuroQol five dimensions
(EQ-5D-5 L)) [27], and quality of life (dementia quality
of life tool (DEMQoL)) [28]. Proxy completion of the
EQ-5D questionnaire by a member of staff who knows
the resident well will also be undertaken for all par-
ticipating residents. Additionally, where residents are
unable to answer the questions themselves, proxy com-
pletion of the DEMQoL questionnaire will be under-
taken. Appropriate staff members will also be asked to
complete questionnaires about physical function and
mobility (Functional Ambulation Classification (FAC)
and Elderly Mobility Scale (EMS])) of resident(s) they
know well. Where possible, the same staff member will
provide data for a particular resident throughout the
study. Any staff member acting as a nominated con-
sultee will not act as a staff proxy informant so that they
remain independent of the research.
Residents who give their consent will be asked to wear
an ActiGraph wGT3X-BT accelerometer (Actigraph,
Pensacola, FL, USA) on the right hip, secured using an
elasticated belt, during waking hours over the course of
7 days to record PA through movement counts collected
over 60-s epochs. Valid wear time will be defined as
≥8 h 25 min on ≥4 days. For residents who provide valid
data, the amount of time spent in various PA categories
[29] and in sedentary behaviour will be identified using
cut-points applied to the vertical axis accelerometer
counts per minute (cpm) (see Table 2). A detailed proto-
col will be followed for administration of the accelerom-
eters which will take place after the data collection
defined above to ensure that accelerometer wear does
not interfere with residents’ routine PA levels and influ-
ence their questionnaire outcome assessments.
Adverse event data will be collected by a researcher on
a monthly basis and the best method of collecting ser-
vice use data will be explored, including data routinely
recorded by the care home as well as, where possible,
via receipt of hospital attendance data from NHS Digital
and relevant Acute Hospital Trusts.
Process evaluation
A mixed-method approach will be employed with differ-
ent stakeholders, at different levels (all homes; all inter-
vention homes; purposive sub-sample of intervention
and control homes).
Data will be collected across all 12 trial homes to de-
scribe usual care and the contextual factors within and
outwith the care home environment that affect resident
PA and sedentary time over the period of the trial.
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Researchers will use a qualitative, trial-specific observa-
tional tool at each data collection time point to obtain
insights into residents’ PA at different times, in different
locations, and in respect of residents with different types
of need. They will also complete a chronology of
organisational (including staffing) policy and practice
changes that have occurred in the 3 months preceding
data collection. Qualitative interviews will be conducted
with a senior member of staff in each home at the con-
clusion of the trial by the dedicated process evaluation
researcher(s) to explore the value attached to ‘moving
more’ and how this may have changed over the period of
the research.
Across all intervention homes, data will be collected
on the intervention and implementation process by the
process evaluation researcher and programme facilita-
tors. This will include audio recordings of the workshops
and collection of documentary data relating to the cyc-
lical process of change over time (observation, action
planning, and review sheets). Information will be
Table 1 Summary and timing of assessments
Assessment Method of completion Timeline
Screening Baseline 3 months 6 months 9 months
Care home eligibility Researcher assessment X
Resident screening (demographics) Researcher assessment X
Physical Activity and Mobility in Residential
Care Scale (PAM-RC) and Barthel index
Researcher interview/
self-completion (S)
X X X X
Resident consent (including consultee) Self-completion (R)
(witnessed)
X
Resident eligibility Researcher assessment X
Contact details (including consultee, staff informant/
proxy if applicable)
Researcher assessment X
Care home demographics Researcher interview (S) X X X X
Staff profile Researcher interview (S) X X X X
Home level mortality rates, hospital admissions, HCP contacts, and
adverse events
Researcher interview (S) X X X X
Staff details questionnaire (including the
Person-centred Care Assessment Tool (P-CAT))
Self-completed (S) X X X X
Functional Ambulation Classification (FAC), and the
Elderly Mobility Scale (EMS)
Researcher interview/
self-completion (S)
X X X X
Level of cognitive impairment (6-CIT) Researcher interview (R) X X X X
Mood (Geriatric Depression Scale (GDS)) Researcher interview (R) X X X X
Perceived health (EQ-5D-5 L) Researcher interview/
proxy completion (R/SP)
X X X X
Quality of life (DEMQOL) Researcher interview/
proxy completion (R/SP)
X X X X
Accelerometer measurements Researcher assessment X X X X
Health Economics Questionnaire Researcher interview (S)/
review of care notes
X X X X
Service usage Routine data sources Collected throughout
Hospital admissions/safety reporting Researcher assessment/
routine data sources
Collected throughout
Usual care review Researcher assessment
(observations)
X X X X
Intervention delivery and adherence Researcher assessment X X X X
6-CIT Six-item Cognitive Impairment Test, DEMQOL Dementia quality of life tool, EQ-5D EuroQoL five dimensions, HCP, Health Care Professional R resident, S care
home staff, SP staff proxy
Table 2 Accelerometer cut-points
Accelerometer counts
per minute (cpm)
PA classification Examples of activities
<100 cpm Sedentary Sitting, reclining
100–759 cpm Low intensity PA Upper body movements
760–2019 cpm Light intensity PA Self care, slow walk
≥2020 cpm Moderate-vigorous
(MV) PA
Walking, sit-stand
transfers
PA physical activity
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gathered on which residents have been chosen for action
and their characteristics; which domains of “moving
more” have been targeted and with what effect; and
which staff, occupying which roles, are nominated to
provide support and encouragement to residents to engage
in more PA. Qualitative interviews will be undertaken with
the care home’s intervention lead to explore how the inter-
vention is understood, engaged with, and enacted by differ-
ent stakeholders in the real life context of individual care
homes, and examine how both intervention and contextual
factors facilitate, delay, or impede change.
Within a sub-sample of two intervention and two
control homes, ethnographic observations of levels of
movement within public areas will be conducted by the
process evaluation researcher(s) alongside informal
discussion with residents about their experience of, and
attitudes to, ‘moving more’, and interviews with staff gen-
erally about the value they attach to PA and practices in
relation to it. These data will allow in-depth evaluation of
how the intervention enhances attitudes towards and
practices relating to PA among staff and residents over the
study duration, over and above any changes that may be
introduced within the control homes. Within the inter-
vention homes, it will also contribute to understanding
whether change occurs in the pattern of PA and sedentary
behaviour over time, as well as in the engagement and
reach of the intervention to staff and residents.
Within the sub-sample of two intervention homes,
data on the theories of change and how these are
enacted and impact on the pattern of movement over
time will be collected through observation of implemen-
tation team meetings, review of documents relating to
the service improvement cycle, and interviews with
members of care staff, including the intervention lead,
over the course of implementation. Since implementa-
tion is conceived of as a process and not a one-off event
[30], documenting the process as it evolves over time
and in relation to contextual factors in the care home is
considered necessary. Analysis will be based on the prin-
ciples of grounded theory [31].
Economic evaluation
A within-trial cost effectiveness analysis will be under-
taken from the perspective of the NHS and Personal
Social Care Sectors. It will compare costs and outcomes
over the 9-month follow-up period between each arm.
The analysis will use quality-adjusted life years (QALYs)
derived from responses to the EQ-5D-5 L and EQ-5D-5 L
proxy [32]. Cost estimates will be based on NHS resource
use (accident and emergency/unplanned hospital admis-
sions, falls, soft tissue injuries, NHS and non-NHS service
use) collected from care notes and via a health economics
questionnaire completed by researcher interviews with
staff at 3, 6, and 9 months post-randomisation. The
resources associated with implementation and delivery of
the intervention will be included in the analysis. These will
be based on routine data such as administrative records,
trial-specific data collected during implementation, and a
detailed description of the implementation and develop-
ment process provided by the researchers involved in
intervention implementation. Unit costs for health service
resources will be obtained from national sources such as
the Personal Social Services Research Unit (PSSRU), the
British National Formulary (BNF), and NHS Reference
cost database [33]. The non-parametric bootstrap method
will be used to produce a within-trial probabilistic sensitiv-
ity analysis of the incremental cost effectiveness ratio.
Longer term cost effectiveness will be estimated using a
decision analytical model. The long-term cost effectiveness
modelling will adopt the same perspective as the within-
trial analysis and will follow good practice guidelines [34].
A value of information analysis will be undertaken [35].
Sample size
We aim to recruit 12 residential care homes (six per
arm) with an average of 8–12 participating residents per
home, based on recruitment in our earlier studies. A
formal power calculation is not appropriate in this feasi-
bility trial as effectiveness is not being evaluated. How-
ever, this target sample size allows us to maintain
sufficient power for an effect size of 0.50 and above
across the outcome measures while increasing the Type
I error rate from 0.05 to 0.20 (Table 3). Increasing the
Type I error rate provides assurance that the interven-
tion is promising and warrants further evaluation given
that we are making a preliminary and non-definitive ran-
domised comparison of the intervention with usual care.
It is recognised that, with an increased false-positive rate
in this feasibility trial, a definitive trial may not show an
intervention effect at the care home level; however, suffi-
cient changes at an individual level may be detected
which would also be of interest. The results generated
from this study will be used to inform the sample size
for a definitive trial.
Table 3 Anticipated power for a range of effect sizes across
outcome measures with six clusters per arm, not accounting for
losses to follow-up
Effect size ICC Power (cluster size = 8) Power (cluster size = 12)
0.40 0.05 65% 74%
0.10 59% 65%
0.50 0.05 79% 87%
0.10 72% 78%
0.60 0.05 89% 94%
0.10 83% 88%
ICC intra-class correlation coefficient (which represents the amount of correlation
between observations (residents) within a cluster (care home))
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Analysis
Statistical analysis of the quantitative elements of the
trial is the responsibility of the CTRU statistician, and a
detailed statistical analysis plan will be written and
agreed before data are analysed. No formal interim
analyses are planned and final analysis will take place
when all available data have been received and the
database has been cleaned and locked. Analyses and data
summaries will be conducted on an intention-to-treat
population, defined as according to randomisation and
regardless of non-compliance with the protocol or
withdrawal from the study. The focus of analyses will be
descriptive statistics and confidence interval (CI) estima-
tion rather than formal hypothesis testing, with the
exception of a preliminary estimate of effectiveness.
Recruitment uptake and follow-up
To assess feasibility of recruitment, the number of
homes and residents screened, eligible, and providing
consent/assent will be summarised, alongside reasons
for non-participation. Retention during follow-up, in-
cluding the number, timing, and reasons of withdrawals,
will be reported overall and by study arm to assess
whether there are any systematic differences between
the arms which could be attributed to the intervention.
The number of residents moving in and out of the care
home will also be recorded.
Intervention delivery and compliance
Actual intervention delivery will be assessed using trial-
specific documentation (case report forms), as well as
through detailed process evaluation work. Documentation
will allow reporting of the number of care homes failing
to progress through implementation milestones and rea-
sons for failure to implement any aspects of the interven-
tion. This includes: the intervention workshops (including
a summary of workshop content and attendees); the pres-
ence and content of action plans; and the level of support
provided by the research team members responsible for
intervention training to enhance intervention implemen-
tation. Implementation processes will be assessed in more
depth via qualitative analysis of the process evaluation
data, including observations of implementation team
meetings, interviews with staff, informant conversations,
and detailed field notes.
Characterising usual care
Specific initiatives relating to enhancing any part of resi-
dent care and any materials displayed in the care homes
relating to PA (or the context of ‘moving more’), such as
leaflets or posters, will be summarised at each time point
and by arm. Care home and staff characteristics will be
summarised to inform the context in which the inter-
vention was delivered, as well as staff turn-over resulting
in employment at other trial care homes to assess the
degree of contamination.
Assessment of outcome measures
The number and proportion of questionnaires received
at each time point will be summarised overall and by
study arm. Point estimates for resident scores will be
calculated for each outcome measure, together with CIs
for the differences in scores between the study arms.
The amount of missing data will also be presented.
To inform the feasibility of monitoring levels of PA and
sedentary behaviour, the number and proportion of resi-
dents who wear an accelerometer and the daily wear time
will be summarised by arm at each time point, alongside
the reasons for residents not wearing the accelerometer.
Preliminary estimate of the effectiveness of the intervention
Through the use of accelerometers we are able to derive
several different PA and sedentary behaviour end-points.
We will be able to assess the amount of time residents
spend sedentary and in low, light, and moderate to vig-
orous intensity physical activity (MVPA). We can also
assess the number of daily bouts (defined as consecutive
minutes) of specified lengths spent in these categories.
Examples of such end-points include:
 Percentage of time spent sedentary and in
low-intensity categories
 Number of daily sedentary bouts of >60 min
 Number of daily sedentary bouts of >30 min
 Number of daily bouts of low intensity >5 min
 Total length of time spent sedentary or in
low-intensity physical activity
 The total time spent achieving any MVPA
For each PA outcome of interest (as detailed above)
measured using the accelerometers, point estimates will
be calculated by study arm based on cluster-level sum-
maries, together with a range of CIs (95%, 80%, 67%,
and 51%) to give a greater indication of the direction
and effect size we might expect to see in a large-scale
trial. Data will be reported separately at baseline and at
each follow-up time point.
Following a review of the summaries for each of the
PA outcomes, the most appropriate end-point for future
use in the large-scale trial will be selected. This decision
will be made on the basis of both the summary data and
any emerging evidence on physiological effects (for ex-
ample, that increasing the number of breaks in sedentary
behaviour is more important than reducing the total
amount of sedentary behaviour). No information will be
provided split by treatment arm at this stage to avoid
selection bias. Once this decision has been made we will
then summarise these end-points by trial arm.
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A preliminary estimation of effectiveness will be car-
ried out using methods appropriate for cluster rando-
mised trials with a small number of clusters [36]. Point
estimates of the 9-month outcome in each arm will be
used to obtain difference or ratio estimates of the inter-
vention effect depending on the type of outcome chosen.
If the distribution of the summary measures in each arm
is skewed, a logarithmic transformation will be consid-
ered. Cluster-level summaries will be used to obtain an
80% CI for the intervention effect and hypothesis testing
will be conducted at the 20% significance level using the
t test.
Adjustment for covariates will be carried out using a
two-stage process. In the first stage, a standard regres-
sion model including the covariates of interest, but ex-
cluding the intervention effect, will be fitted to calculate
cluster-specific expected values. Expected and observed
values will be compared by computing a residual for
each cluster. These cluster residuals will then be ana-
lysed using methods based on the t test in the second
stage of analysis.
To inform the sample size for a definitive trial,
unadjusted and adjusted estimates of the ICC will be
calculated alongside the amount of between-cluster
variability in study outcomes and cluster size.
Process evaluation
Qualitative data (field notes, interviews, informant con-
versations, audio workshop recordings) will be analysed
using grounded theory analytic strategies [31] combining
simultaneous data collection and analysis, constant com-
parison, and search for negative cases. This approach
provides a more robust, systematic, and in-depth ap-
proach to addressing issues of context and process over
time, critical in this study.
Analysis will be conducted at several levels. For each
care home, multiple sources of data will be drawn upon
to provide a descriptive narrative account of the physical
environment, organisation, staffing, resident profile, and
pattern of PA and sedentary behaviour of residents. For
intervention homes the process of understanding, en-
gaging with, and implementing the intervention in the
context of each care home will be analysed, drawing on
documents and interviews with the intervention leads.
Through comparison between intervention homes we
will identify how the level of engagement with the inter-
vention, the domains of action and the reach of the
intervention across staff and residents vary, the factors
that shape these, and how they affect the outcomes of
the trial. Additional data relating to the actual process of
implementation in time from the sub-sample of inter-
vention homes will enable exploration of the theory of
change underpinning the intervention and implementa-
tion process.
Progression criteria for continuation to the definitive
randomised controlled trial
Guidelines for progression to a definitive RCT are based
on a traffic light system of green (proceed to RCT
design), amber (review RCT design and/or implementa-
tion, then proceed), red (stop and do not proceed), and
are detailed in Additional file 3.
Trial organisation and governance
The REACH trial is sponsored by the Bradford Teaching
Hospitals NHS Foundation Trust and is co-ordinated by
the Academic Unit of Elderly Care and Rehabilitation
(Bradford Teaching Hospitals NHS Foundation Trust
and University of Leeds) and the CTRU (Clinical Trials
Research Unit, University of Leeds). The trial manage-
ment group consists of the co-applicants and the teams
from the co-ordinating units. The study will be con-
ducted in accordance with the Research Governance
Framework for Health and Social Care (2005) and CTRU
standard operating procedures.
Overall trial supervision is provided by the Programme
Steering Committee (PSC), with an independent Chair
and ‘Patient and Public Involvement’ (PPI) representa-
tion. A sub-group of the PSC will perform a safety moni-
toring function since a separate data monitoring and
ethics committee is not required for a feasibility trial of
this nature and duration.
Data will be entered, managed, and monitored for
quality and completeness by the CTRU. Missing data
(except individual items collected via questionnaires) will
be chased until received, confirmed as not available, or
the trial is at analysis. Data will be stored and managed
in accordance with the provisions of the Data Protection
Act (1998).
Dissemination
Results of the study will be published in peer-review
publications and will be presented at national and inter-
national conferences. We will work with the PPI repre-
sentatives to develop lay reports to disseminate research
findings to resident and relative groups and the care
home staff at participating homes.
Authorship will be agreed in accordance with the
REACH Programme publication policy and in line with
International Committee of Medical Journal Editors
(ICMJE) recommendations.
Discussion
As the population ages the numbers at the oldest ages
will increase the fastest. In 2008, there were 1.3 million
people in the UK aged 85 years and over; this is pro-
jected to rise to 1.8 million by 2018 [37]. One conse-
quence is an increase in demand for long-term care
which, despite the increased emphasis on community
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care [38], will remain a necessary component of health
and social care provision [2]. Residents of care homes
are amongst the frailest in our population with signifi-
cant health and social care needs [39, 40]. It is reported
that older people [41] and care home residents under-
take little PA [4, 42] and in fact spend the majority of
their time sedentary [43]. Although “there is sufficient
evidence to support a recommendation to reduce seden-
tary behaviour in older adults” [42], the majority of such
work relates to younger people, and the implications for
older adults are not yet robust. Decreasing levels of PA
and increasing dependency have many adverse effects.
Reduced PA and mobility problems compound health
difficulties by directly affecting physical and psycho-
logical health, and reducing opportunities to participate
in social activities [6].
We aim to address this challenge in our programme of
work in which we are evaluating an intervention which ac-
tively engages staff within care homes to embed strategies
to increase PA and decrease sedentary behaviour during
the daily routines of the care home and its residents. This
‘whole-home’ intervention moves away from a model of
time-limited provision of activities such as exercise classes.
Research in this setting in challenging; this feasibility trial
will address important methodological issues, assess inter-
vention implementation, and collect data to inform a de-
finitive RCT to evaluate an intervention which addresses a
central component of care for frail, elderly people. The
work undertaken will also provide guidance and tested pro-
tocols for all research undertaken in the care home setting.
Trial status
The study commenced recruitment of care homes in
August 2015, and recruitment of residents in December
2015; 138 residents at 11 care homes had been recruited
as of 31 August 2016. The study is projected to complete
recruitment by September 2016.
Additional files
Additional file 1: SPIRIT 2013 checklist: recommended items to address
in a clinical trial protocol and related documents. (DOC 123 kb)
Additional file 2: REACH trial information and consent documentation.
This document includes all information sheets and consent forms
provided to the care home manager, residents, relatives, and staff
members involved in the trial. (PDF 1306 kb)
Additional file 3: Progression criteria for continuation to the definitive
randomised controlled trial. This document details guidelines for
progression to a definitive randomised controlled trial (RCT) which are
based on a traffic light system of green (proceed to RCT design), amber
(review RCT design and/or implementation, then proceed), or red
(stop and do not proceed). (DOCX 20 kb)
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